Infectious Diseases (all articles) | Page 178 of 298 | Links Medicus Content Curation & Alerts in Medicine

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

18 Sep, 2020 | 09:34h | UTC

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong – Nature Medicine

Commentary: Superspreaders of SARS-CoV-2 – Virology Blog

Commentaries on Twitter

Cases linked to #superspreading events are estimated to account for 80% of all local transmission of #SARSCoV2 in Hong Kong in a study with implications for public health policies. @bencowling88 @gmleunghku @SCauchemez @DillonCAdam @hkumed #quarantine https://t.co/tniPhKNhs5

— Nature Medicine (@NatureMedicine) September 17, 2020

We can learn a lot about superspreader events from this new @NatureMedicine paper https://t.co/ouO7CyGXQE by @DillonCAdam @bencowling88 @gmleunghku @hkumed
The Pareto 80/20 rule applied: 19% of infections were responsible for 80% of transmissions; 69% of cases did not transmit

— Eric Topol (@EricTopol) September 17, 2020

Covid-19: Do many people have pre-existing immunity?

18 Sep, 2020 | 09:41h | UTC

Covid-19: Do many people have pre-existing immunity? – The BMJ

Commentary on Twitter

It seemed a truth universally acknowledged that the human population had no pre-existing immunity to SARS-CoV-2, but is that actually the case? Peter Doshi explores the emerging research on immunological responseshttps://t.co/6LYRjxlWBQ

— The BMJ (@bmj_latest) September 17, 2020

Change in antibodies to SARS-CoV-2 over 60 days among health care personnel

18 Sep, 2020 | 09:32h | UTC

Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee -JAMA

Commentary on Twitter

In this cohort study, anti–SARS-CoV-2 antibodies decreased over 60d in HCWs w 58% becoming seronegative. The results suggest that x-sectional seroprevalence studies may underestimate rates of prior infections because Abs may only be transiently detectable https://t.co/IHgURuDJYm

— JAMA (@JAMA_current) September 18, 2020

The new Covid-19 case surge in Europe, explained

18 Sep, 2020 | 09:29h | UTC

The new Covid-19 case surge in Europe, explained – Vox

Cochrane publishes three rapid reviews of the evidence on different public health measures to slow the spread of COVID-19

18 Sep, 2020 | 09:33h | UTC

Cochrane publishes three rapid reviews of the evidence on different public health measures to slow the spread of COVID-19 – Cochrane Library

See update reviews: How effective is screening for COVID-19? AND Can travel-related control measures contain the spread of the COVID-19 pandemic? AND Does quarantine control coronavirus (COVID-2019) either alone or in combination with other public health measures?

Commentary on Twitter

📣 3 rapid reviews of the evidence on different #publichealth measures to slow the spread of COVID-19 https://t.co/QShfHABEpL Quarantine, travel-related control measures, and Universal screening. – Open-access in @CochraneLibrary – #COVID #COVID19 pic.twitter.com/HqyQtYErfK

— The Cochrane Library (@CochraneLibrary) September 17, 2020

Two pharma companies released their coronavirus vaccine blueprints in a bid to regain public trust

18 Sep, 2020 | 09:30h | UTC

Two Pharma Companies Released Their Coronavirus Vaccine Blueprints In A Bid To Regain Public Trust – BuzzFeed

Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients

18 Sep, 2020 | 09:27h | UTC

Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients – International Journal of Infectious Diseases

Commentary on Twitter

More evidence for aerosol transmission "Viable #SARSCoV2 isolated from air samples 2-4.8 m away from patients…genome sequence isolated from material collected by air samplers identical to isolates from newly admitted patient". https://t.co/mvPJEmvMjV

— MJA Editor in Chief (@MJA_Editor) September 18, 2020

Study: Longer-than-necessary duration of outpatient antibiotic therapy for common outpatient infections

18 Sep, 2020 | 09:21h | UTC

Duration of outpatient antibiotic therapy for common outpatient infections – Clinical Infectious Diseases

Commentary on Twitter

NEW #CID using large NDTI dataset,clinicians defaulted 10d courses for most conditions, regardless of guideline-recommendations. Median antibiotic course
duration was 10 days for all conditions except acute cystitis. #IDTwitter https://t.co/WTJBFEcRtk pic.twitter.com/TAx7twUoTo

— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) September 16, 2020

WHO Guidance: Allocation and prioritization of COVID-19 vaccination

17 Sep, 2020 | 09:42h | UTC

WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination – World Health Organization

Commentary: World Health Organization announces distribution plan for COVID-19 vaccine – ABD News

A case of probable Parkinson’s disease after SARS-CoV-2 infection

17 Sep, 2020 | 09:40h | UTC

A case of probable Parkinson’s disease after SARS-CoV-2 infection – The Lancet Neurology

Commentary on Twitter

Parkinson's disease diagnosed after #SARSCoV2 in a 45 year-old-man https://t.co/SPLKDm1A2U @TheLancetNeuro
This has been reported with many other viruses but appears to be the 1st case with covid, very extensive workup pic.twitter.com/AtQfQXxjtm

— Eric Topol (@EricTopol) September 17, 2020

How COVID-19 can damage the brain

17 Sep, 2020 | 09:36h | UTC

How COVID-19 can damage the brain – Nature

Commentary on Twitter

How COVID-19 can damage the brain https://t.co/uQUS5y9AXU 125 people in the United Kingdom with COVID-19 who had neurological or psychiatric effects. 62% had strokes and haemorrhages, and 31% had altered mental states, such as confusion or prolonged unconsciousness.

— Carlos del Rio (@CarlosdelRio7) September 16, 2020

Antimicrobial resistance: The next big pandemic?

18 Sep, 2020 | 09:19h | UTC

Antimicrobial resistance: The next big pandemic? – Open Access Government

Detection of SARS-CoV-2 with a CRISPR-based test

17 Sep, 2020 | 09:38h | UTC

Detection of SARS-CoV-2 with a CRISPR-Based Test – New England Journal of Medicine

Fast coronavirus tests: what they can and can’t do

17 Sep, 2020 | 09:35h | UTC

Fast coronavirus tests: what they can and can’t do – Nature

Opinion: “Is lockdown worth the pain? No, it’s a sledgehammer and we have better options”

17 Sep, 2020 | 09:31h | UTC

Is lockdown worth the pain? No, it’s a sledgehammer and we have better options – The Conversation

[Press release – not published yet] Eli Lilly reports first, promising results for an antibody against COVID-19

17 Sep, 2020 | 09:28h | UTC

Eli Lilly reports first, promising results for an antibody against COVID-19 – Science

Press release: Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting

Updated Cochrane Rapid Review assesses the effectiveness of quarantine during the COVID-19 pandemic

17 Sep, 2020 | 09:32h | UTC

Updated Cochrane Rapid Review assesses the effectiveness of quarantine during the COVID-19 pandemic – Cochrane Library

Full review: Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review – Cochrane Library

Commentary on Twitter

Recently published: https://t.co/lLM4ehhyro Updated @cochranecollab Rapid Review assesses the effectiveness of #quarantine during the #COVID-19 pandemic. It includes 51 relevant studies – 22 more than in the first version. @CochraneAus pic.twitter.com/ME5CiuTzUa

— The Cochrane Library (@CochraneLibrary) September 16, 2020

CDC Study: Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19

17 Sep, 2020 | 09:29h | UTC

Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020 – CDC Morbidity and Mortality Weekly Report

Commentary on Twitter

.@CDCMMWR report looking at almost 600 hospitalized pregnant women with #COVID19 found that pregnant women can have severe illness and poor birth outcomes, such as the mother requiring intensive care, pregnancy loss, and preterm birth. Learn more: https://t.co/g7WsFWJdDs. pic.twitter.com/Ve0dnGNTDM

— CDC (@CDCgov) September 16, 2020

Investigating whether blood type is linked to COVID-19 risk

17 Sep, 2020 | 09:26h | UTC

Investigating Whether Blood Type Is Linked to COVID-19 Risk – JAMA

Commentary on Twitter

Researchers find no relationship between blood type and severe #COVID19, despite early studies suggesting possible higher risk for those with type A. “The basic science on this is extremely weak.” https://t.co/tYreg896DK

— JAMA (@JAMA_current) September 17, 2020

Gates Foundation COVID-19 Report: A Global Perspective

16 Sep, 2020 | 09:19h | UTC

2020 Goalkeepers Report – Covid-19: A Global Perspective – Bill & Melinda Gates Foundation

Commentaries: 25 years wiped out in 25 weeks: Pandemic sets the world back decades – Politico AND New report says Covid-19 pandemic has caused historic setbacks in global health – STAT AND The COVID-19 Pandemic Has Erased Decades of Progress on Childhood Vaccination – TIME

Gates Foundation report:

— Vaccination coverage is dropping to 1990s-era levels

— Nearly 37M more people globally are now living on less than $1.90 per day

Gates: “We’ve been set back about 25 years in about 25 weeks.”

Shocking stuff from @carmenpaun.https://t.co/FPDzCxqDhw

— Dan Diamond (@ddiamond) September 15, 2020